MENU
FBLG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

FibroBiologics (FBLG) Ownership - Who owns FibroBiologics?

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid... Show more

Profile

Industry
N/A
Address
455 East Medical Center Boulevard
Phone
+1 281 671-5150
Employees
15
Web
https://www.fibrobiologics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.85M
P/E Ratio
N/A
Total Cash
1.48M
Projected Growth
N/A
Total Debt
2.48M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.28
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
FBLG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
455 East Medical Center Boulevard
Phone
+1 281 671-5150
Employees
15
Web
https://www.fibrobiologics.com